最新の試験


EudraCT Number: 2019-002636-82 Sponsor Protocol Number: OTL-200-07 Start Date:
Sponsor Name: Orchard Therapeutics (Europe) Limited
Full Title: An open label, non-randomised trial to evaluate the safety and efficacy of a single infusion of OTL-200 in patients with Late Juvenile (LJ) Metachromatic Leukodystrophy (MLD)
Medical condition: Metachromatic Leukodystrophy
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10067609 Metachromatic leukodystrophy PT
Population Age: Children, Under 18 Gender: Male, Female
Trial protocol: IT (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-005914-33 Sponsor Protocol Number: VX21-445-125 Start Date:
Sponsor Name: Vertex Pharmaceuticals Incorporated
Full Title: A Phase 3 Open-label Study Evaluating the Longterm Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis Subjects With Non-F508del CFTR Genotypes
Medical condition: Cystic Fibrosis
Disease: Version SOC Term Classification Code Term Level
20.0 10010331 - Congenital, familial and genetic disorders 10011762 Cystic fibrosis PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: DE (Ongoing) ES (Ongoing) SE (Ongoing) NO (Ongoing) NL (Ongoing) IT (Ongoing) BE (Ongoing) AT (Ongoing) PT (Ongoing) PL (Ongoing) HU (Ongoing) CZ (Ongoing)
Trial results: (No results available)
EudraCT Number: 2007-002420-15 Sponsor Protocol Number: RIC2006 Start Date:
Sponsor Name: Universität Leipzig
Full Title: Phase II-Studie zur Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Flud...
Medical condition: Effizienz der vorzeitigen Reduktion von CSA/MMF bei fallendem linienspezifischen Chimärismus nach allogener Stammzelltransplantation nach Konditionierung mit low-dose TBI/Fludarabin bei älteren ...
Disease: Version SOC Term Classification Code Term Level
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: (No results available)

EudraCT Number: 2015-001496-48 Sponsor Protocol Number: OTI179 Start Date:
Sponsor Name: BIOCODEX
Full Title: Evaluation de l'efficacité d’une solution de chlorhydrate de lidocaïne 1% et de phénazone 4% en gouttes auriculaires (Otipax®) dans l’otite moyenne aiguë congestive de l’enfant Etude clinique ouv...
Medical condition: Congestive acute otitis media of children
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: FR (Completed)
Trial results: (No results available)
EudraCT Number: 2021-005455-37 Sponsor Protocol Number: 178-CL-207 Start Date:
Sponsor Name: Astellas Pharma Global Development Inc.
Full Title: A Phase 3, Open Label, Multicenter, Baseline-Controlled Sequential Dose Titration Study Followed by a Fixed Dose Observation Period to Evaluate Pharmacokinetics, Efficacy and Safety of Mirabegron P...
Medical condition: Neurogenic detrusor overactivity (NDO)
Disease: Version SOC Term Classification Code Term Level
21.1 100000004857 10012547 Detrusor hyperreflexia LLT
23.1 100000004857 10059617 Overactive bladder LLT
Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: BE (Ongoing) DK (Trial now transitioned) PL (Ongoing)
Trial results: (No results available)

EudraCT Number: 2008-004583-40 Sponsor Protocol Number: 101010 Start Date:
Sponsor Name: Universitaetsklinikum Muenster
Full Title: A randomized, multi-center phase II trial to assess the efficay of 5-azacytidine added to standard primery therapy in elderly patients with newly diagnosed AML.
Medical condition: The disease under investigation is newly diagnosed Acute Myeloid Leucemia (AML) in elderly patients.
Disease: Version SOC Term Classification Code Term Level
13.1 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) 10000880 Acute myeloid leukaemia PT
Population Age: Adults, Elderly Gender: Male, Female
Trial protocol: DE (Completed)
Trial results: View results
EudraCT Number: 2020-002936-55 Sponsor Protocol Number: MSC-EB_2020 Start Date:
Sponsor Name: Masarykova univerzita
Full Title: Safety and Efficacy of Allogenic Adipose Tissue-derived Mesenchymal Stromal Cells in Patients with Epidermolysis Bullosa: Clinical Trial Phase I/II
Medical condition: Epidermolysis bullosa congenita
Disease: Version SOC Term Classification Code Term Level
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: CZ (Ongoing)
Trial results: (No results available)

EudraCT Number: 2021-002482-17 Sponsor Protocol Number: TAK-935-3003 Start Date:
Sponsor Name: Takeda Development Center Americas, Inc
Full Title: A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or ...
Medical condition: Dravet Syndrome (DS) Lennox-Gastaut Syndrome (LGS)
Disease: Version SOC Term Classification Code Term Level
20.0 100000004850 10073682 Dravet syndrome LLT
20.1 10029205 - Nervous system disorders 10048816 Lennox-Gastaut syndrome PT
Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
Trial protocol: BE (Ongoing) ES (Ongoing) NL (Ongoing) HU (Ongoing) FR (Ongoing) GR (Ongoing) IT (Ongoing) LV (Ongoing) PL (Ongoing) Outside EU/EEA
Trial results: (No results available)
EudraCT Number: 2012-002328-34 Sponsor Protocol Number: KB056 Start Date:
Sponsor Name: KEDRION S.P.A
Full Title: Efficacy and safety evaluation of Kedrion Fibrin Sealant as an adjuvant for the control of hemostasis in pediatric patients undergoing abdominal or orthopedic surgery. Multicenter, randomized, cont...
Medical condition: Paediatric patients undergoing abdominal or orthopedic surgery
Disease: Version SOC Term Classification Code Term Level
18.0 10042613 - Surgical and medical procedures 10067439 Haemostasis PT
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
Trial protocol: IT (Prematurely Ended)
Trial results: (No results available)

EudraCT Number: 2015-003019-39 Sponsor Protocol Number: Start Date:
Sponsor Name:
Full Title: Efficacy & Safety of Nasal Influenza Immunisation in Children - The SNIFFLE-3 study
Medical condition: Children aged 2-18 years (inclusive), some of whom will have asthma and/or food allergies.
Disease: Version SOC Term Classification Code Term Level
18.0 100000004870 10001738 Allergy LLT
Population Age: Children, Adolescents, Under 18 Gender: Male, Female
Trial protocol: GB (Completed)
Trial results: View results
3